Panduranga Adulla Reddy

Statistics

Publications

Citations

196

H-Index

Active since

1999

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Panduranga Adulla Reddy is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, drug discovery, and ligand-based design.

Publications per year

1999–2013

Publications

Small Molecule JNK (c-Jun N-Terminal Kinase) Inhibitors

M. Arshad Siddiqui, Panduranga Adulla Reddy · Journal of Medicinal Chemistry · 2010 · 75 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +12

Design and synthesis of potent Gram-negative specific LpxC inhibitors

Umar Faruk Mansoor, Panduranga Adulla Reddy, Dayna L. Daubaras et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 44 citations · Full text

Pharmacy, Medicinal Chemistry, Drug Design +11

Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitors

Xiaohua Huang, Cliff C. Cheng, Thierry Fischmann et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 35 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Identification of simian cyclophilin A as a calreticulin-binding protein in yeast two-hybrid screen and demonstration of cyclophilin A interaction with calreticulin

Panduranga Adulla Reddy, Chintamani D. Atreya · International Journal of Biological Macromolecules · 1999 · 16 citations

Life Sciences, Biochemistry, Molecular Biology +6

Bioisosteric approach to the discovery of imidazo[1,2-a]pyrazines as potent Aurora kinase inhibitors

Zhaoyang Meng, Bheemashankar A. Kulkarni, Angela D. Kerekes et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 16 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

1–5 of 6